"Designing Growth Strategies is in our DNA"
The global spinal cord stimulation market size was USD 2,268.9 million in 2018 and is projected to reach USD 4,236.2 million by the end of 2026, exhibiting a CAGR of 8.1%.
Neuromodulation is an emerging therapy involving targeted delivery of electromagnetic or chemical stimulation to a specific neurological area in the body. One of the neuromodulation technique is spinal cord stimulation which involves the delivery of electrical stimuli to the spinal cord resulting in masking of pain. Spinal cord stimulation is receiving increased worldwide attention which can be attributed to the emerging government guidelines for spinal cord stimulation treatment procedures.
Get comprehensive study about this report by, request a free sample copy
Furthermore, the market is boosted by the introduction of rechargeable pulse stimulator which is less costly than non-rechargeable pulse stimulators. The use of spinal cord stimulators reduces the intake of opioids and other pain-relieving drugs. The emerging applications of spinal cord stimulation for pain management are likely to accelerate the spinal cord stimulation market growth in the forecast duration.
"Implantable Pulse Generator Dominate the Global Spinal Cord Stimulation Market"
The implantable pulse generator segment dominated the market with a dominating share in 2018. The cost-effectiveness of the rechargeable pulse generator has resulted in greater preference and higher sales volume of the implantable pulse generator. Furthermore, the launch of new products in the market such as Spectra WaveWriter in Europe, Intellis in Canada, and others have made rechargeable implantable pulse generator as the fastest-growing segment. This is further projected to surge the spinal cord stimulation market revenue in the foreseeable future.
To get details on market share, speak to our analyst
In terms of disease indication, the market is categorized into Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), arachnoiditis and others. The Failed Back Syndrome (FBS) segment is estimated to have a major portion of the market owing to increased government efforts to develop a new therapy for chronic back pain and increased prevalence across the globe. Various end-users covered under the report are hospitals, ambulatory surgical centers, specialty clinics. These end-users are increasingly adopting spinal cord stimulators, aiding the market size.
"North America to Dominate the Global Spinal Cord Stimulation Industry"
North America was dominating the global market with a maximum revenue of US$ 1,086.7 Mn in 2018 and will continue to remain a dominating segment throughout the forecast period. Emerging government guidelines and favorable health reimbursement are the factors responsible for the expansion of the market in North America during 2018-2026. Europe is anticipated to be the second most prominent region in terms of revenue by 2026.
The launch of the Spectra WaveWriter spinal cord stimulator system by Boston Scientific Corporation in January 2019 is poised to surge the growth of the spinal cord stimulation market in Europe. Asia Pacific is projected to register the highest CAGR during the forecast period owing to the higher demand and rapid adoption due to the increased presence of the aging population in this region.
North America Spinal Cord Stimulation Market Share, 2018
To get geographical overview of this market, request a free sample copy
"Boston Scientific Corporation and Abbott to Account for More Than Half of the Market Share in Terms of Revenue"
Boston Scientific Corporation and Abbott hold a major portion of the market owing to strategic acquisition by Abbott and new product launch by Boston Scientific Corporation. In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., which resulted in the acquisition of spinal cord stimulation and other products. This further increased the spinal cord stimulation market share of Abbott globally. Other players operating in the global market are Medtronic, Stimwave LLC, Nevro Corp., Nuvectra, and other players.
Spinal cord stimulation is one of the neuromodulation technique in which electrical impulses are delivered to the spinal cord in order to mask the pain signal. The introduction of MRI conditional spinal cord stimulators, favorable health reimbursement, emerging government guidelines, and positive recommendations are the major factors for the increased demand for spinal cord stimulation therapy. Also, the significant reduction in the intake of opioid medications has increased the preference for spinal cord stimulators among the patients.
The report provides qualitative and quantitative insights on the spinal cord stimulation industry and detailed analysis of market size and growth rate for all possible segments in the market. The market is segmented by product type, disease indication, and end-user. Based on the product, the global spinal cord stimulation market is segmented into the implantable pulse generator and radiofrequency system. The implantable pulse generator segment can be further classified into rechargeable and non-rechargeable. In terms of disease indication, the market is categorized into Failed Back Syndrome (FBS), Degenerative Disk Disease (DDD), Complex Regional Pain Syndrome (CRPS), arachnoiditis, and others.
Various end-users covered under the report are hospitals, ambulatory surgical centers, and specialty clinics. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.
To get information on various segments, share your queries with us
Along with this, the report provides an elaborative analysis of the market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of chronic back pain for key countries, new product launch, the regulatory scenario for key countries, global reimbursement overview, recent industry developments such as mergers & acquisitions and key industry trends.
By Disease Indication
By End User
Fortune Business Insights says that the spinal cord stimulation market is projected to reach USD 4,236.2 Million by 2026.
In 2018, the spinal cord stimulation market was valued at USD 2,268.9 Million.
Growing at a CAGR of 8.1%, the market will exhibit steady growth in the forecast period (2019-2026).
Implantable pulse generator segment is expected to be leading in the market during the forecast period.
Emerging applications of spinal cord stimulation for pain management to drive the global spinal cord stimulation market.
Boston Scientific Corporation and Abbott are the top players in the spinal cord stimulation market.
North America is expected to hold the highest market share in the market.
Advancements in the spinal cord stimulation systems, implantable generators, and introduction of cost-effective rechargeable stimulators are the trends expected to increase the market value of spinal cord stimulation.
Availability of portable stimulators and cost-effective stimulators that help in masking chronic pain to drive the adoption of spinal cord stimulation services.